Gazyva 1000MG/40ML 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FATLD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,304
Award facts
- Contract value 100% obligated
- $41,303.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $41,303.76 by the Defense Logistics Agency (DLA) on January 6, 2026, for the supply of GAZYVA 1000MG/40ML, a pharmaceutical product. This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of January 28, 2026. The award is issued as a child contract under AmerisourceBergen's parent organization, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen's role as a critical pharmaceutical distributor within the federal supply chain is demonstrated through its extensive portfolio of medical product deliveries to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's capability to fulfill federal procurement requirements across multiple therapeutic domains—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—has established it as a strategic vendor for military and veteran healthcare systems. This delivery order for GAZYVA, a cancer treatment medication, exemplifies the company's continued support of essential pharmaceutical needs within the Department of Defense's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FATLD?
SPE2DR26FATLD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FATLD worth?
The government has obligated $41,304 on SPE2DR26FATLD.
Is contract SPE2DR26FATLD an order under another contract?
Yes. SPE2DR26FATLD is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FATLD competed?
The extent of competition for SPE2DR26FATLD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award